NCT01381341View on ClinicalTrials.gov

To Compare Relative Bioavailability of Two Clinical Formulations of Linifanib.

PHASE1CompletedINTERVENTIONAL

Enrollment

13

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

Advanced Solid Tumors

Interventions

DRUG

linifanib

QD on Day 1 of Periods 1 and 2

Trial Locations (1)

98405

Site Reference ID/Investigator# 51403, Tacoma

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Abbott

INDUSTRY